Biotechnology Industry Organization (BIO)

Release Summary

The Pharmaceutical Cost Transparency Act of 2015 (AB 463) does nothing to improve patient access to medicines that have been put virtually out of reach by insurance company specialty tiers.

Biotechnology Industry Organization (BIO)